Research Papers:

A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis

Renata Binato _, Everton Cruz Santos, Mariana Boroni, Samia Demachki, Paulo Assumpção and Eliana Abdelhay

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:7359-7371. https://doi.org/10.18632/oncotarget.23670

Metrics: PDF 1938 views  |   HTML 2659 views  |   ?  


Renata Binato1,2,*, Everton Cruz Santos1,2,*, Mariana Boroni3, Samia Demachki4, Paulo Assumpção4 and Eliana Abdelhay1,2

1Laboratório de Célula tronco, Centro de Transplante de Medula Óssea (CEMO), Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil

2Instituto Nacional de Ciência e Tecnologia Para o Controle do Câncer (INCT), Rio de Janeiro, RJ, Brazil

3Laboratório de Bioinformática e Biologia Computacional, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil

4Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará (UFPA), Belém, PA, Brazil

*These authors contributed equally to this work

Correspondence to:

Renata Binato, email: [email protected]

Keywords: molecular signature; intestinal-type gastric carcinoma; brazilian molecular profile; common molecular signature worldwide

Received: March 22, 2017     Accepted: December 11, 2017     Published: December 27, 2017


Gastric carcinoma (GC) is one of the most aggressive cancers and the second leading cause of cancer death in the world. According to the Lauren classification, this adenocarcinoma is divided into two subtypes, intestinal and diffuse, which differ in their clinical, epidemiological and molecular features. Several studies have attempted to delineate the molecular signature of gastric cancer to develop new and non-invasive screening tests that improve diagnosis and lead to new treatment strategies. However, a consensus signature has not yet been identified for each condition. Thus, this work aimed to analyze the gene expression profile of Brazilian intestinal-type GC tissues using microarrays and compare the results to those of non-tumor tissue samples. Moreover, we compared our intestinal-type gastric carcinoma profile with those obtained from populations worldwide to assess their similarity. The results identified a molecular signature for intestinal-type GC and revealed that 38 genes differentially expressed in Brazilian intestinal-type gastric carcinoma samples can successfully distinguish gastric tumors from non-tumor tissue in the global population. These differentially expressed genes participate in biological processes important to cell homeostasis. Furthermore, Kaplan-Meier analysis suggested that 7 of these genes could individually be able to predict overall survival in intestinal-type gastric cancer patients.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23670